BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29246939)

  • 1. Merkel Cell Carcinoma Patients Presenting Without a Primary Lesion Have Elevated Markers of Immunity, Higher Tumor Mutation Burden, and Improved Survival.
    Vandeven N; Lewis CW; Makarov V; Riaz N; Paulson KG; Hippe D; Bestick A; Doumani R; Marx T; Takagishi S; Chan TA; Choi J; Nghiem P
    Clin Cancer Res; 2018 Feb; 24(4):963-971. PubMed ID: 29246939
    [No Abstract]   [Full Text] [Related]  

  • 2. Merkel Cell Carcinoma from Molecular Pathology to Novel Therapies.
    Stachyra K; Dudzisz-Śledź M; Bylina E; Szumera-Ciećkiewicz A; Spałek MJ; Bartnik E; Rutkowski P; Czarnecka AM
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial.
    D'Angelo SP; Bhatia S; Brohl AS; Hamid O; Mehnert JM; Terheyden P; Shih KC; Brownell I; Lebbé C; Lewis KD; Linette GP; Milella M; Georges S; Shah P; Ellers-Lenz B; Bajars M; Güzel G; Nghiem PT
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32414862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy.
    Goh G; Walradt T; Markarov V; Blom A; Riaz N; Doumani R; Stafstrom K; Moshiri A; Yelistratova L; Levinsohn J; Chan TA; Nghiem P; Lifton RP; Choi J
    Oncotarget; 2016 Jan; 7(3):3403-15. PubMed ID: 26655088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality Is King: Fundamental Insights into Tumor Antigenicity from Virus-Associated Merkel Cell Carcinoma.
    Lahman MC; Paulson KG; Nghiem PT; Chapuis AG
    J Invest Dermatol; 2021 Aug; 141(8):1897-1905. PubMed ID: 33863500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on Merkel Cell Carcinoma.
    Harms PW
    Clin Lab Med; 2017 Sep; 37(3):485-501. PubMed ID: 28802497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recent update on tumour biology and treatment of Merkel Cell carcinoma].
    Steinstraesser L; Kueckelhaus M; Koljonen V
    Handchir Mikrochir Plast Chir; 2011 Dec; 43(6):345-9. PubMed ID: 22241518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UV Signature Mutations Reclassify Salivary High-grade Neuroendocrine Carcinomas as Occult Metastatic Cutaneous Merkel Cell Carcinomas.
    Sun L; Cliften PF; Duncavage EJ; Lewis JS; Chernock RD
    Am J Surg Pathol; 2019 May; 43(5):682-687. PubMed ID: 30986802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale for immune-based therapies in Merkel polyomavirus-positive and -negative Merkel cell carcinomas.
    Vandeven N; Nghiem P
    Immunotherapy; 2016 Jul; 8(8):907-21. PubMed ID: 27381685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Distinctive Mutational Spectra of Polyomavirus-Negative Merkel Cell Carcinoma.
    Harms PW; Vats P; Verhaegen ME; Robinson DR; Wu YM; Dhanasekaran SM; Palanisamy N; Siddiqui J; Cao X; Su F; Wang R; Xiao H; Kunju LP; Mehra R; Tomlins SA; Fullen DR; Bichakjian CK; Johnson TM; Dlugosz AA; Chinnaiyan AM
    Cancer Res; 2015 Sep; 75(18):3720-3727. PubMed ID: 26238782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Genomic Landscape of Merkel Cell Carcinoma and Clinicogenomic Biomarkers of Response to Immune Checkpoint Inhibitor Therapy.
    Knepper TC; Montesion M; Russell JS; Sokol ES; Frampton GM; Miller VA; Albacker LA; McLeod HL; Eroglu Z; Khushalani NI; Sondak VK; Messina JL; Schell MJ; DeCaprio JA; Tsai KY; Brohl AS
    Clin Cancer Res; 2019 Oct; 25(19):5961-5971. PubMed ID: 31399473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunobiology of Merkel cell carcinoma: implications for immunotherapy of a polyomavirus-associated cancer.
    Bhatia S; Afanasiev O; Nghiem P
    Curr Oncol Rep; 2011 Dec; 13(6):488-97. PubMed ID: 21953511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Outcomes Among Immunosuppressed Patients With Merkel Cell Carcinoma: Impact of Immunosuppression Type on Cancer-specific and Overall Survival.
    Cook M; Baker K; Redman M; Lachance K; Nguyen MH; Parvathaneni U; Bhatia S; Nghiem P; Tseng YD
    Am J Clin Oncol; 2019 Jan; 42(1):82-88. PubMed ID: 30211723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Profiling of Multiple Primary Merkel Cell Carcinoma to Distinguish Genetically Distinct Tumors From Clonally Related Metastases.
    Harms KL; Lazo de la Vega L; Hovelson DH; Rahrig S; Cani AK; Liu CJ; Fullen DR; Wang M; Andea AA; Bichakjian CK; Johnson TM; Tomlins SA; Harms PW
    JAMA Dermatol; 2017 Jun; 153(6):505-512. PubMed ID: 28403382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Insights and Advances in the Management of Merkel Cell Carcinoma.
    Banks PD; Sandhu S; Gyorki DE; Johnston ML; Rischin D
    J Oncol Pract; 2016 Jul; 12(7):637-46. PubMed ID: 27407160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Merkel cell polyomavirus-specific CD8⁺ and CD4⁺ T-cell responses identified in Merkel cell carcinomas and blood.
    Iyer JG; Afanasiev OK; McClurkan C; Paulson K; Nagase K; Jing L; Marshak JO; Dong L; Carter J; Lai I; Farrar E; Byrd D; Galloway D; Yee C; Koelle DM; Nghiem P
    Clin Cancer Res; 2011 Nov; 17(21):6671-80. PubMed ID: 21908576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Therapeutic Advances and Change in Treatment Paradigm of Patients with Merkel Cell Carcinoma.
    Garcia-Carbonero R; Marquez-Rodas I; de la Cruz-Merino L; Martinez-Trufero J; Cabrera MA; Piulats JM; Capdevila J; Grande E; Martin-Algarra S; Berrocal A
    Oncologist; 2019 Oct; 24(10):1375-1383. PubMed ID: 30962295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in Immunotherapy for Metastatic Merkel Cell Carcinoma: A Clinician's Guide.
    Paulson KG; Bhatia S
    J Natl Compr Canc Netw; 2018 Jun; 16(6):782-790. PubMed ID: 29891528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and immune targets for Merkel cell carcinoma therapy and prevention.
    Cohen L; Tsai KY
    Mol Carcinog; 2019 Sep; 58(9):1602-1611. PubMed ID: 31116890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalent and Diverse Intratumoral Oncoprotein-Specific CD8
    Jing L; Ott M; Church CD; Kulikauskas RM; Ibrani D; Iyer JG; Afanasiev OK; Colunga A; Cook MM; Xie H; Greninger AL; Paulson KG; Chapuis AG; Bhatia S; Nghiem P; Koelle DM
    Cancer Immunol Res; 2020 May; 8(5):648-659. PubMed ID: 32179557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.